FOSTER JAMES C sold $7.9M of CRL
FOSTER JAMES C sold 28,733 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) at $275.00 ($7.90M total) on 2026-08-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed event is an open-market sale by a director under a pre-arranged 10b5-1 plan, with no new company performance, guidance, or regulatory information included.
Market read
Traders may note the insider sale for sentiment, but the 10b5-1 structure makes it less actionable as a fundamental catalyst.
What to watch
The article provides no context on total holdings, prior sales cadence, or whether the sale was tax-related, limiting interpretability beyond the fact of selling.
Background
The article is an SEC Form 4 insider transaction disclosure for Charles River Laboratories International, Inc.
Ticker impact
Charles River Laboratories director Foster James C sold 28,733 shares at $275 on 2026-08-10 under a pre-arranged 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely limited to intraday sentiment around the filing.
The filing is an open-market sale by a director, explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed in the text.
Market effects
No sector-level signal; this is company-specific insider transaction data only.
None indicated.
None indicated.
Counterpoint
Insider sales can sometimes precede negative developments, but the presence of a 10b5-1 plan reduces that inference.
Key entities
- issuerCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Subject of the Form 4 insider transaction disclosure.
- insiderFOSTER JAMES C
Director who sold 28,733 shares at $275/share.
